01/27/2025
4:47 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
2:31 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
3:18 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
2:46 PM | GALAPAGOS NV (Subject)
Gilead Sciences (Filed by)
| Form SCHEDULE 13D/A | |
01/03/2025
5:33 PM | Berger Dietmar (Reporting)
Gilead Sciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/03/2025
5:38 PM | Berger Dietmar (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
7:17 PM | ASSEMBLY BIOSCIENCES, INC. (Subject)
Gilead Sciences (Filed by)
| Form SCHEDULE 13D/A | |
12/23/2024
7:26 PM | ASSEMBLY BIOSCIENCES, INC. (Issuer)
Gilead Sciences (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
3:15 PM | Gilead Sciences (Filed by)
Xilio Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G/A | |
12/19/2024
3:19 PM | Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:27 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
12/16/2024
3:22 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:08 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
6:48 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:51 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:24 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:05 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:08 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:13 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
1:43 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
7:10 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
1:35 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
5:14 PM | Bluestone Jeffrey (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
3:15 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
6:31 PM | Bluestone Jeffrey (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2024
3:15 PM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:13 PM | Gilead Sciences (Subject)
| Form FWP | |
11/13/2024
8:02 AM | Gilead Sciences (Filer)
| Form 424B5 | |
11/06/2024
3:19 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
3:07 PM | Gilead Sciences (Subject)
Mercier Johanna (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
3:09 PM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
2:09 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
3:58 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
6:07 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:08 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:43 PM | Gilead Sciences (Subject)
Mercier Johanna (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:45 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
6:30 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
6:33 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
6:38 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
6:41 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump vs. Texas (Ad) Ever since Donald Trump won the election, U.S. states have been rushing to pass new currency rules.
These rules pave the way for the first-ever major threat to the U.S. dollar.
I'm calling it "Plan B". Click here to go to the epicenter of this major financial trend. |
09/11/2024
6:20 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
6:23 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
2:23 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
1:23 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
4:17 PM | Gilead Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024
4:28 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
8:01 AM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
7:06 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
7:31 PM | ASSEMBLY BIOSCIENCES, INC. (Issuer)
Gilead Sciences (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
7:35 PM | ASSEMBLY BIOSCIENCES, INC. (Subject)
Gilead Sciences (Filed by)
| Form SC 13D/A | |
06/11/2024
6:12 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:15 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:18 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:20 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:23 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:25 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:57 PM | BARTON JACQUELINE K (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:16 PM | Gilead Sciences (Issuer)
MANWANI HARISH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:23 PM | Gilead Sciences (Issuer)
WELTERS ANTHONY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:26 PM | Gilead Sciences (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:30 PM | Gilead Sciences (Issuer)
LOVE TED W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:08 PM | Bluestone Jeffrey (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
8:29 PM | GALAPAGOS NV (Subject)
Gilead Sciences (Filed by)
| Form SC 13D/A | |
04/19/2024
3:31 PM | Gilead Sciences (Reporting)
LEAP THERAPEUTICS, INC. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/19/2024
3:31 PM | Gilead Sciences (Filed by)
LEAP THERAPEUTICS, INC. (Subject)
| Form SC 13G | |
04/05/2024
3:31 PM | Gilead Sciences (Filed by)
Xilio Therapeutics, Inc. (Subject)
| Form SC 13G | |
04/03/2024
5:48 PM | Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
5:50 PM | Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:38 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
4:19 PM | Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:07 PM | Gilead Sciences (Filer)
| Form DEF 14A | |
03/28/2024
3:07 PM | Gilead Sciences (Filer)
| Form DEFA14A | |
03/22/2024
8:21 AM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
6:50 AM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/20/2024
3:12 PM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/15/2024
3:11 PM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/12/2024
3:19 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:11 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:14 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:59 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:03 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:34 AM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T/A | |
02/29/2024
5:35 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:49 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:38 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
5:09 AM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T | |
02/13/2024
4:48 PM | Gilead Sciences (Reporting)
Kyverna Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
7:37 AM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
7:39 AM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-C | |
02/09/2024
5:21 PM | Capital World Investors (Filed by)
Gilead Sciences (Subject)
| Form SC 13G/A | |
Grab This Altcoin Before Trump's Crypto Announcement (Ad) The #1 Coin Poised to Soar Under Trump
Pro-Crypto White House could make this the investment opportunity of a lifetime!
 Click HERE to access this free report before it's too late |
02/07/2024
4:35 PM | Gilead Sciences (Reporting)
Kyverna Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2024
5:01 PM | Gilead Sciences (Issuer)
LOVE TED W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:20 PM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
1:42 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
1:34 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
1:19 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
1:11 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
12:40 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:58 PM | Arcus Biosciences, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC 13D/A | |
